Share ownership SpyGlass Pharma, Inc.
Equities
SGP
US85220G1094
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.73 USD | +0.86% |
|
+11.30% | - |
| Mar. 26 | SpyGlass Pharma, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 | CI |
| Mar. 22 | SpyGlass Pharma, Inc.(NasdaqGS:SGP) added to S&P TMI Index | CI |
Major shareholders: SpyGlass Pharma, Inc.
| Name | Equities | % | Valuation |
|---|---|---|---|
RA Capital Management LP
24
%
| 8,021,117 | 24 % | 208 M $ |
NEA Management Co. LLC
22.12
%
| 7,392,301 | 22.12 % | 192 M $ |
Vensana Capital Management LLC
9.904
%
| 3,310,619 | 9.904 % | 86 M $ |
Sands Capital Alternative LLC
7.479
%
| 2,500,012 | 7.479 % | 65 M $ |
Gilde Healthcare Partners BV
6.544
%
| 2,187,513 | 6.544 % | 57 M $ |
Samsara BioCapital LLC
6.312
%
| 2,109,953 | 6.312 % | 55 M $ |
2.615
%
| 873,978 | 2.615 % | 23 M $ |
0.8283
%
| 276,877 | 0.8283 % | 7 M $ |
0.5479
%
| 183,153 | 0.5479 % | 5 M $ |
0.2873
%
| 96,022 | 0.2873 % | 2 M $ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
Breakdown by shareholder type
| Institutional | 76.35% |
| Individuals | 4.28% |
| Unknown | 19.37% |
Based on 1000 largest holdings
Geographical origin of shareholders
United States | 69.81% |
Netherlands | 6.54% |
Individuals
| 4.28% |
Based on 1000 largest holdings
- Stock Market
- Equities
- SGP Stock
- Company SpyGlass Pharma, Inc.
- Share ownership
Select your edition
All financial news and data tailored to specific country editions
